Navigation Links
Resverlogix Notice of Conference Call & Webcast
Date:8/21/2008

TSX Exchange Symbol: RVX

CALGARY, Aug. 21 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) is pleased to announce that it will host a live teleconference on August 25, 2008 at 11:00 am MDT to provide a corporate update of the Company. Following the presentation there will be a live question and answer session.

The webcast can be accessed at the following link:

http://services.choruscall.com/links/resverlogix080825.html

Participants can also dial in for the conference call:

Dial information is as follows:

North American Toll Free Dial In: 1-800-319-4610

International Dial In: +1-604-638-5340

The webcast will be available on the Resverlogix website for replay for a period of 10 days after the event.

About Resverlogix Corp.

Resverlogix Corp. is a leading biotechnology company engaged in the development of novel therapies for important global medical markets with significant unmet needs. The NexVas(TM) program is the Company's primary focus which is to develop novel small molecules that enhance ApoA-I. These vital therapies address the grievous burden of atherosclerosis and other important diseases such as acute coronary syndrome, diabetes, Alzheimer's and other vascular disorders. The Company's secondary focus is TGF-Beta Shield(TM), a program that aims to address burgeoning grievous diseases, such as cancer and fibrosis. Resverlogix Corp. trades on the Toronto Stock Exchange (TSX:RVX). For further information please visit http://www.resverlogix.com.

This news release may contain certain forward-looking statements that reflect the current views and/or expectations of Resverlogix Corp. with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties
'/>"/>

SOURCE Resverlogix Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Jan Gray Joins Resverlogix Board of Directors
2. Resverlogixs Lead Drug Featured in Key Scientific Publication
3. Industry Leaders Select Resverlogixs RVX-208
4. /C O R R E C T I O N from Source -- Resverlogix Corp./
5. Resverlogix Notice of Conference Call & Webcast
6. Resverlogix Share Option Extension
7. FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208
8. Resverlogix Honoured with World Economic Forum Technology Pioneer Award
9. Resverlogix is Presenting at IAS HDL Workshop
10. Resverlogix Presents Key Apo-Al/HDL Scientific Data at DALM
11. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Norris, TN (PRWEB) September 16, 2014 ... several new initiatives to position themselves for ... capabilities for labeling and encoding, Pharma Packaging ... adding new hardware and software and new ... on current Good Manufacturing Practices (cGMP), Pharma ...
(Date:9/16/2014)... ORLEANS , Sept. 16, 2014 In ... Austin, Texas -based cybersecurity company focused on authentication ... ONE, will support the ability to generate a OTP ... As a pioneer of user-based RFID authentication, 2FA,s ... for physical access, for many years. RFID authentication is ...
(Date:9/15/2014)... 2014   Global Science & Technology, Inc. ... and services for satellite and weather systems, was ... Services (OASIS) from the General Services Administration (GSA) ... provide the government best-value solutions for complex professional ... in Pool 4. The OASIS SB award has ...
(Date:9/15/2014)... patient has sepsis, a life-threatening condition in which bacteria ... too fast for antibiotics to help. A new device ... team at Harvard,s Wyss Institute for Biologically Inspired Engineering ... , "Even with the best current treatments, sepsis patients ... percent of the time," said Mike Super, Ph.D., Senior ...
Breaking Biology Technology:Adding Serialization Capabilities and Expanded Capacity, Pharma Packaging Solutions Is Preparing for 89th Year of Business 22FA, Inc. Announces RFID-based One-Time Password (OTP) Authentication 2Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 2Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 3Blood-cleansing biospleen device developed for sepsis therapy 2Blood-cleansing biospleen device developed for sepsis therapy 3Blood-cleansing biospleen device developed for sepsis therapy 4
... Enterprise level ... bank. , ... 2009 -- PacsDrive, LLC. ( www.pacsdrive.com ), a medical imaging software company, announced ... and medium sized health care providers to securely archive medical imaging in compliance with HIPAA ...
... , HUNTINGTON BEACH, California and ... diagnostics, announced today that,Palmetto GBA, California,s Part B Medicare administrator, ... Agendia,s,FDA-cleared breast cancer recurrence test, which has been reimbursed by,payors ... United States can now submit claims for the,MammaPrint test directly ...
... , ATLANTA, Dec. 1 GeoVax Labs, ... biopharmaceutical company developing human vaccines for diseases caused by HIV-1 ... support for World AIDS Day. , "Today is the 21st ... have lost their fight with the HIV/AIDS pandemic, we remain ...
Cached Biology Technology:PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT 2Medicare Administrator Establishes Reimbursement Coding Policy for Agendia's Breast Cancer Recurrence Test MammaPrint(R) 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 4GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 5GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 6
(Date:9/16/2014)... associated with increased rates and intensity of tobacco smoking. ... relationship between schizophrenia and smoking stems, in part, from ... symptoms and cognitive impairment associated with the disease. , ... Biological Psychiatry , sheds light on this hypothesis. ... in the brain was lower in schizophrenia patients than ...
(Date:9/16/2014)... . CRG researchers ... Journal of Cell Biology describes how Topo 2 ... , At this very moment thousands of our body,s cells ... the body repairs damaged tissues and regenerates others like skin ... "mitosis", during which the cell duplicates its genetic material and ...
(Date:9/16/2014)... Valdez spilled 11 million gallons of oil into Alaska,s ... giant oil spill in the Gulf of Mexico in ... Journal of Consumer Research , news coverage of environmental ... catalyzing changes in the way fossil fuels are used. ... of these two events helped to resolve many of ...
Breaking Biology News(10 mins):Smoking and schizophrenia linked by alterations in brain nicotine signals 2Unraveling cell division 2Unraveling cell division 3Exxon Valdez 2014: Does media coverage of manmade disasters contribute to consumer complacency? 2
... A new book featuring a series of interviews ... available from the Inter-American Network of Academies of Sciences ... highlights the inclusion and empowerment of women in science ... Juan Pedro Laclette say in the book,s introduction that ...
... March 8, 2013 Dr. Eric Olson , chairman ... 2013 recipient of the March of Dimes Prize in Developmental ... the heart and other muscles. His work is credited ... could lead to novel treatments for heart disease and muscle ...
... a new method for attaching proteins to the surface ... membrane proteins. This enables time-resolved tracking of the interactions ... is accurate down to atomic resolution. The method is ... K4DD", in which scientists explore the interplay of drugs ...
Cached Biology News:New book celebrates women scientists in the Americas 2UTSW molecular biologist Olson wins March of Dimes developmental biology prize 2Specialised germanium surface as universal protein adapter 2Specialised germanium surface as universal protein adapter 3
Request Info...
Kit containing positive control DNA all parts of the HIV-1 genome, HIV-1 negative control DNA, Primers SK38, SK39, SK19...
Contains 0.2 g/L EDTA4Na in phosphate-buffered saline....
Immunochemistry 1 & 2...
Biology Products: